Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_5f81a68e4e7650968a414e2f691f72bc |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-172 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-156 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-158 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-118 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6883 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-37 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-55 |
filingDate |
2010-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1fc80021c8da0e620bc7da877524f04d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8068951e4540f4e1fcb306efcb1a8cc8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_78ae948b15d640371adfbab7baadd6fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b950563dda44599425ae407867f4eed9 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cb8a5d549080a8b98102c42384e508ee |
publicationDate |
2011-04-14-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-2011086796-A1 |
titleOfInvention |
Methods for predicting the development and resolution of acute respiratory distress syndrome |
abstract |
The subject invention features methods for predicting whether a subject at risk of developing Acute Respiratory Distress Syndrome (ARDS) will develop ARDS by determining the amount of elafin present in a subject sample, or by determining the ration of elafin:neutrophil elastase in a subject sample. The invention also features methods for monitoring the efficacy of a treatment regimen for ARDS as well as methods of treatment for ARDS. The invention also features methods to determine a subject's predisposition for developing ARDS by determining whether certain genomic polymorphisms are present in the subject's DNA. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023132348-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11216742-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10627289-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2017298445-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11468355-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9663712-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010023342-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2019169158-A |
priorityDate |
2007-11-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |